Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Livestock Healthcare Market: By Livestock Animal, By Product Type, By Distribution Channel, By End User, and Geography
Livestock Healthcare Market size was valued at US$ 40.53 billion in 2022 and is poised to grow at a CAGR of 6.4% from 2023-2029. The increasing prevalence of food-borne and zoonotic disease across the globe in livestock animals. Growing meat and milk consumption every year coupled with the adoption of animals for agriculture purposes is increasing and the rising support from the government to take initiatives to boost the growth of veterinary products and treatments are expected to drive the growth of the market over the forecast years. Furthermore, market players focusing on the technological advancements in the healthcare industry to provide the best treatment option available are projected to boost the growth of the market.
However, the cost of the vaccines and medications available in the market are not affordable which has become a major restraining factor for the growth of the market. This report studies global livestock healthcare market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, This report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the global market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Study Period
2024-2030Base Year
2023CAGR
6.4%Largest Market
North-AmericaFastest Growing Market
North-America
Zoonotic diseases or infections are the diseases that are naturally transmitted from animals to humans. Zoonotic diseases are very common, both in the United States and across the world. According to Centers for Disease Control and Prevention (CDC), scientists evaluate that more than 6 out of every 10 known infectious diseases in people are spread from animals, and 3 out of every 4 new or evolving infectious diseases in people are spread from animals. Every year, tens of thousands of Americans will get sick from harmful germs spread between animals and people.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 40.53 billion |
Market CAGR |
6.4% |
By Product Type |
|
By Livestock Animal |
|
By Distribution Channel |
|
By End User |
|
Download Free Sample Report
The livestock healthcare market is projected to expand at a CAGR of 6.4% during the forecast period
Bayer Healthcare AG, Ceva Santé Animale, Virbac S.A,Vetoquinol SA, Boehringer Ingelheim GmbH
North America is the fastest-growing region for livestock healthcare market
1. Executive Summary |
2. Global Livestock Healthcare Market Introduction |
2.1. Global Livestock Healthcare Market - Taxonomy |
2.2. Global Livestock Healthcare Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Livestock Animal |
2.2.3. By Distribution Channel |
2.2.4. By Region |
3. Global Livestock Healthcare Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Livestock Healthcare Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
4.1. Vaccines |
4.1.1. Live Attenuated Vaccines |
4.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.1.3. Market Opportunity Analysis |
4.1.2. DNA Vaccines |
4.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.2.3. Market Opportunity Analysis |
4.1.3. Recombinant Vaccines |
4.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.3.3. Market Opportunity Analysis |
4.1.4. Inactivated Vaccines |
4.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.4.3. Market Opportunity Analysis |
4.1.5. Others |
4.1.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.1.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.5.3. Market Opportunity Analysis |
4.2. Pharmaceuticals |
4.2.1. Parasiticides |
4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.1.3. Market Opportunity Analysis |
4.2.2. Anti-infectives |
4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.2.3. Market Opportunity Analysis |
4.2.3. Anti-inflammatory |
4.2.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.3.3. Market Opportunity Analysis |
4.2.4. Analgesics |
4.2.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.4.3. Market Opportunity Analysis |
4.2.5. Others |
4.2.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.5.3. Market Opportunity Analysis |
4.3. Feed Additives |
4.3.1. Antibiotics |
4.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.3.1.3. Market Opportunity Analysis |
4.3.2. Vitamins |
4.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.2.3. Market Opportunity Analysis |
4.3.3. Amino acids |
4.3.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.3.3. Market Opportunity Analysis |
4.3.4. Feed enzymes |
4.3.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.4.3. Market Opportunity Analysis |
4.3.5. Antioxidants |
4.3.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.5.3. Market Opportunity Analysis |
4.4. Diagnostics |
4.4.1. Instruments |
4.4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.4.1.3. Market Opportunity Analysis |
4.4.2. Consumables |
4.4.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.4.2.3. Market Opportunity Analysis |
4.4.3. Others |
4.4.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.4.3.3. Market Opportunity Analysis |
4.5. Others |
4.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.5.3. Market Opportunity Analysis |
5. Global Livestock Healthcare Market By Livestock Animal, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Poultry |
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Swine |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Cattle |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Sheep & Goats |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Horse |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Livestock Healthcare Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Retail |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. E-commerce |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Veterinary Hospitals & Clinics |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Livestock Healthcare Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Livestock Healthcare Market - Opportunity Analysis Index, By Livestock Animal, Product Type, Distribution Channel, , , , , and Region, 2023-2029 |
8. North America Livestock Healthcare Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Vaccines |
8.1.1.1. Live Attenuated Vaccines |
8.1.1.2. DNA Vaccines |
8.1.1.3. Recombinant Vaccines |
8.1.1.4. Inactivated Vaccines |
8.1.1.5. Others |
8.1.2. Pharmaceuticals |
8.1.2.1. Parasiticides |
8.1.2.2. Anti-infectives |
8.1.2.3. Anti-inflammatory |
8.1.2.4. Analgesics |
8.1.2.5. Others |
8.1.3. Feed Additives |
8.1.3.1. Antibiotics |
8.1.3.2. Vitamins |
8.1.3.3. Amino acids |
8.1.3.4. Feed enzymes |
8.1.3.5. Antioxidants |
8.1.4. Diagnostics |
8.1.4.1. Instruments |
8.1.4.2. Consumables |
8.1.4.3. Others |
8.1.5. Others |
8.2. Livestock Animal Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Poultry |
8.2.2. Swine |
8.2.3. Cattle |
8.2.4. Sheep & Goats |
8.2.5. Horse |
8.2.6. Others |
8.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1. Retail |
8.3.2. E-commerce |
8.3.3. Veterinary Hospitals & Clinics |
8.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.4.1. USA |
8.4.2. Canada |
9. Europe Livestock Healthcare Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Vaccines |
9.1.1.1. Live Attenuated Vaccines |
9.1.1.2. DNA Vaccines |
9.1.1.3. Recombinant Vaccines |
9.1.1.4. Inactivated Vaccines |
9.1.1.5. Others |
9.1.2. Pharmaceuticals |
9.1.2.1. Parasiticides |
9.1.2.2. Anti-infectives |
9.1.2.3. Anti-inflammatory |
9.1.2.4. Analgesics |
9.1.2.5. Others |
9.1.3. Feed Additives |
9.1.3.1. Antibiotics |
9.1.3.2. Vitamins |
9.1.3.3. Amino acids |
9.1.3.4. Feed enzymes |
9.1.3.5. Antioxidants |
9.1.4. Diagnostics |
9.1.4.1. Instruments |
9.1.4.2. Consumables |
9.1.4.3. Others |
9.1.5. Others |
9.2. Livestock Animal Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Poultry |
9.2.2. Swine |
9.2.3. Cattle |
9.2.4. Sheep & Goats |
9.2.5. Horse |
9.2.6. Others |
9.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Retail |
9.3.2. E-commerce |
9.3.3. Veterinary Hospitals & Clinics |
9.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1. Germany |
9.4.2. France |
9.4.3. Italy |
9.4.4. Spain |
9.4.5. UK |
9.4.6. Rest of Europe |
10. Asia Pacific Livestock Healthcare Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Vaccines |
10.1.1.1. Live Attenuated Vaccines |
10.1.1.2. DNA Vaccines |
10.1.1.3. Recombinant Vaccines |
10.1.1.4. Inactivated Vaccines |
10.1.1.5. Others |
10.1.2. Pharmaceuticals |
10.1.2.1. Parasiticides |
10.1.2.2. Anti-infectives |
10.1.2.3. Anti-inflammatory |
10.1.2.4. Analgesics |
10.1.2.5. Others |
10.1.3. Feed Additives |
10.1.3.1. Antibiotics |
10.1.3.2. Vitamins |
10.1.3.3. Amino acids |
10.1.3.4. Feed enzymes |
10.1.3.5. Antioxidants |
10.1.4. Diagnostics |
10.1.4.1. Instruments |
10.1.4.2. Consumables |
10.1.4.3. Others |
10.1.5. Others |
10.2. Livestock Animal Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Poultry |
10.2.2. Swine |
10.2.3. Cattle |
10.2.4. Sheep & Goats |
10.2.5. Horse |
10.2.6. Others |
10.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Retail |
10.3.2. E-commerce |
10.3.3. Veterinary Hospitals & Clinics |
10.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1. China |
10.4.2. Japan |
10.4.3. South Korea |
10.4.4. India |
10.4.5. Rest of APAC |
11. Latin America Livestock Healthcare Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Vaccines |
11.1.1.1. Live Attenuated Vaccines |
11.1.1.2. DNA Vaccines |
11.1.1.3. Recombinant Vaccines |
11.1.1.4. Inactivated Vaccines |
11.1.1.5. Others |
11.1.2. Pharmaceuticals |
11.1.2.1. Parasiticides |
11.1.2.2. Anti-infectives |
11.1.2.3. Anti-inflammatory |
11.1.2.4. Analgesics |
11.1.2.5. Others |
11.1.3. Feed Additives |
11.1.3.1. Antibiotics |
11.1.3.2. Vitamins |
11.1.3.3. Amino acids |
11.1.3.4. Feed enzymes |
11.1.3.5. Antioxidants |
11.1.4. Diagnostics |
11.1.4.1. Instruments |
11.1.4.2. Consumables |
11.1.4.3. Others |
11.1.5. Others |
11.2. Livestock Animal Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Poultry |
11.2.2. Swine |
11.2.3. Cattle |
11.2.4. Sheep & Goats |
11.2.5. Horse |
11.2.6. Others |
11.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Retail |
11.3.2. E-commerce |
11.3.3. Veterinary Hospitals & Clinics |
11.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Brazil |
11.4.2. Mexico |
11.4.3. Argentina |
11.4.4. Rest of Latin America |
12. MEA Livestock Healthcare Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Vaccines |
12.1.1.1. Live Attenuated Vaccines |
12.1.1.2. DNA Vaccines |
12.1.1.3. Recombinant Vaccines |
12.1.1.4. Inactivated Vaccines |
12.1.1.5. Others |
12.1.2. Pharmaceuticals |
12.1.2.1. Parasiticides |
12.1.2.2. Anti-infectives |
12.1.2.3. Anti-inflammatory |
12.1.2.4. Analgesics |
12.1.2.5. Others |
12.1.3. Feed Additives |
12.1.3.1. Antibiotics |
12.1.3.2. Vitamins |
12.1.3.3. Amino acids |
12.1.3.4. Feed enzymes |
12.1.3.5. Antioxidants |
12.1.4. Diagnostics |
12.1.4.1. Instruments |
12.1.4.2. Consumables |
12.1.4.3. Others |
12.1.5. Others |
12.2. Livestock Animal Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Poultry |
12.2.2. Swine |
12.2.3. Cattle |
12.2.4. Sheep & Goats |
12.2.5. Horse |
12.2.6. Others |
12.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Retail |
12.3.2. E-commerce |
12.3.3. Veterinary Hospitals & Clinics |
12.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1. GCC Countries |
12.4.2. South Africa |
12.4.3. Rest of MEA |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Bayer Healthcare AG |
13.2.2. Ceva Santé Animale |
13.2.3. Virbac S.A |
13.2.4. Vetoquinol SA |
13.2.5. Boehringer Ingelheim GmbH |
13.2.6. Nutreco N.V. |
13.2.7. Sanofi S.A. (MERIAL Limited) |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Key Market Players